Paper Details 
Original Abstract of the Article :
Synaptotagmin-1 (SYT1) plays a pivotal role in regulating presynaptic processes, including neurotransmitter release. SYT1 variants perturb synaptic vesicle endocytosis and exocytosis, resulting in a series of neurodevelopmental disorders defined as Baker-Gordon syndrome. Herein, we report the case o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10048-023-00738-4

データ提供:米国国立医学図書館(NLM)

Unveiling the Lethal Secrets of SYT1: A Case Study of a Newborn with Baker-Gordon Syndrome

The field of [neurodevelopmental disorders] is constantly evolving, and researchers are working tirelessly to unravel the complex mechanisms that underpin these conditions. This study delves into the intricacies of [synaptic vesicle endocytosis and exocytosis], specifically focusing on the role of the [SYT1 gene] in the development of [Baker-Gordon syndrome]. By employing [whole-genome high-throughput DNA sequencing], the authors uncovered a [novel lethal variant] in the [C2A domain] of the [SYT1 gene], which was linked to the severe symptoms observed in the newborn. These findings highlight the crucial role of [SYT1 gene] in normal brain development and underscore the importance of [genetic testing] in diagnosing [neurodevelopmental disorders].

A Deadly Variant: Expanding the Spectrum of SYT1-Associated Neurodevelopmental Disorders

The discovery of this lethal variant in the [C2A domain] of the [SYT1 gene] is particularly noteworthy. It sheds light on the devastating consequences that even subtle mutations in this gene can have on brain development. This case underscores the need for ongoing research to better understand the diverse spectrum of [SYT1-associated neurodevelopmental disorders] and develop effective treatments for these complex conditions.

Hope on the Horizon: Advancing Genetic Testing and Treatment Strategies

While this case study paints a somber picture, it also provides valuable insights for future research. The identification of this novel variant through [whole-genome sequencing] demonstrates the power of [genetic testing] in diagnosing [neurodevelopmental disorders]. This knowledge can empower clinicians to offer more targeted and personalized treatments for individuals with these conditions. Furthermore, a deeper understanding of the [C2A domain] of the [SYT1 gene] may pave the way for the development of novel therapeutic strategies to alleviate the devastating symptoms of [Baker-Gordon syndrome] and other [SYT1-associated neurodevelopmental disorders].

Dr. Camel's Conclusion

This study provides a compelling illustration of how a seemingly small mutation can have a significant impact on the delicate balance of brain development. Like a single grain of sand that can disrupt the stability of an entire sand dune, this variant in the [SYT1 gene] has catastrophic consequences for the newborn's health. This research is like a beacon of hope in the vast desert of [neurodevelopmental disorders], offering a glimmer of light in the ongoing quest for effective therapies.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-06
Further Info :

Pubmed ID

37930470

DOI: Digital Object Identifier

10.1007/s10048-023-00738-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.